The Medical Research Council (MRC) and Wellcome Trust are to invest £24m into obesity research led by the Wellcome Trust-MRC Institute of Metabolic Science (IMS). The IMS, based on the Cambridge Biomedical Campus, will investigate the causes and health consequences of obesity and develop new approaches to prevent and treat metabolic diseases, such as diabetes.
This joint initiative from the MRC and Wellcome Trust will provide exciting new opportunities to better understand the fundamental causes of disease such as obesity and diabetes and translate that knowledge into improved therapies
Professor Stephen O’Rahilly
The IMS is a joint venture between the MRC, Wellcome Trust, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. Co-directed by Professors Steve O’Rahilly and Nick Wareham, it provides a unique environment linking basic and applied science in metabolic diseases.